Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disease (NMOSD)”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Early research (Phase 1)WithdrawnNCT03605238
What this trial is testing

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Chinese PLA General Hospital
Large-scale testing (Phase 3)Study completedNCT04660539
What this trial is testing

Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Hoffmann-La Roche 119
Large-scale testing (Phase 3)Looking for participantsNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Post-approval studies (Phase 4)Looking for participantsNCT07420296
What this trial is testing

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 198
Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Large-scale testing (Phase 3)Study completedNCT02200770
What this trial is testing

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
MedImmune LLC 231
Testing effectiveness (Phase 2)UnknownNCT05356858
What this trial is testing

An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Who this might be right for
Neuromyelitis Optica
Xuanwu Hospital, Beijing 20
Testing effectiveness (Phase 2)Looking for participantsNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Post-approval studies (Phase 4)Ended earlyNCT05269667
What this trial is testing

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 4
Not applicableTemporarily pausedNCT07247292
What this trial is testing

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Who this might be right for
Rare DiseasesNeuromyelitis Optica Spectrum Disorder (NMOSD)
AstraZeneca 100
Early research (Phase 1)Study completedNCT01777412
What this trial is testing

Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 10
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Not applicableLooking for participantsNCT06885957
What this trial is testing

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

Who this might be right for
NMO Spectrum Disorder
Tongji Hospital 200
Not applicableStudy completedNCT05840055
What this trial is testing

ACT with NMOSD Patients and Caregivers Pilot Study

Who this might be right for
NMO Spectrum Disorder
Thomas Jefferson University 43
Not applicableNot Yet RecruitingNCT07159893
What this trial is testing

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Who this might be right for
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
First Affiliated Hospital of Wenzhou Medical University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138
What this trial is testing

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 135
Early research (Phase 1)Looking for participantsNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 37
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Load More Results